Identification of adjuvants for clinical trials performed with Plasmodium falciparum AMA1 in rabbits
Abstract Background In this study, seven adjuvants were compared for use with Plasmodium falciparum DiCo-Apical Membrane Antigen 1 (Pf-DiCo-AMA1), with the aim to identify an ideal adjuvant which yields high antibody titres and potentially broadens the responses in clinical trials. The following adj...
Main Authors: | Sumera Younis, Bart W. Faber, Clemens H.M. Kocken, Edmond J. Remarque |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-07-01
|
Series: | BMC Immunology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12865-019-0307-y |
Similar Items
-
Down selecting adjuvanted vaccine formulations: a comparative method for harmonized evaluation
by: Sumera Y. Younis, et al.
Published: (2018-01-01) -
Characterization of Plasmodium falciparum merozoite apical membrane antigen-1 protein changes prior to erythrocyte invasion
by: Downing, Sarita Louise
Published: (2017) -
Genetic polymorphism in msp-2, ama-1 and csp genes in Plasmodium falciparum field isolates from north and north-western India
by: Umar Farooq, et al.
Published: (2009-06-01) -
Enhanced Anti-Mycobacterium tuberculosis Immunity over Time with Combined Drug and Immunotherapy Treatment
by: Sasha E. Larsen, et al.
Published: (2018-05-01) -
Aspects of immunity for the AMA-1 family of molecules in humans and non-human primates malarias
by: A. W. Thomas, et al.
Published: (1994-01-01)